Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerro-alloy Resources Limited Regulatory News (FAR)

Share Price Information for Ferro-alloy Resources Limited (FAR)

Share Price is delayed by 15 minutes
Get Live Data
4.95    -0.05 (-1.00%)
Bid:
4.80
Ask:
5.10
Spread: 0.30 (6.25%)
Market Cap: £29.09m
FAR Live PriceLast checked at - London Stock Exchange

Intraday Ferro-alloy Resources Limited Share Chart

Exempt Offer Bond Programme - Second Tranche

19 Sep 2023 07:00

RNS Number : 8219M
Ferro-Alloy Resources Limited
19 September 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 (INCLUDING AS IT FORMS PART OF THE LAWS OF ENGLAND AND WALES BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR").

 

19 September 2023

Ferro-Alloy Resources Limited

("Ferro-Alloy" or the "Group" or the "Company")

 

Exempt Offer Bond Programme - Second Tranche

 

Ferro-Alloy Resources Limited (LSE:FAR), the vanadium producer and developer of the large Balasausqandiq vanadium deposit in Southern Kazakhstan, is pleased to announce the launch of the second tranche of the Company's exempt US$20 million offer bond programme valid until 31 July 2033, with a nominal value of US$5m.

 

Summary

· As previously announced on 27 July 2023, the Company launched a new exempt offer bond programme (the "Programme") where all bonds issued under the Programme will be listed on the Astana International Exchange ("AIX") in Kazakhstan.

· The first tranche of bonds (nominal value of US$3m) issued under the Programme have been materially sold (1,447 out of 1,500 units sold) and as a result the Company has launched a second tranche of bonds (the "Second Tranche") with a nominal value of US$5m.

 

Second Tranche

· On 19 September 2023, the Company listed the Second Tranche issued under the Programme on the AIX.

· The proceeds from the sale of the Second Tranche will be used to accelerate the development of the Balasausqandiq project, including front-end engineering.

· A summary of the terms and conditions of the Second Tranche is as follows:

 

- ISIN: KZ000001623

- Specified currency: US Dollars

- Face value: US$100 (one hundred US dollars)

- Number of bonds: 50,000 (fifty thousand) units

- Total nominal amount of the bonds: US$5,000,000 (five million US dollars)

- Issue date: 19 September 2023

- Last date of the circulation period: 18 September 2026

- Maturity date: 19 September 2026

- Coupon rate: 10.0% fixed of the nominal value of the bonds issued

- Frequency of interest payments: quarterly, 19 December, 19 March, 19 June and 19 September of each year during the circulation period, commencing on 19 December 2023

- Coupon basis: 30/360

 

· Trading of the Second Tranche will commence on 20 September 2023.

For further information, visit www.ferro-alloy.com or contact:

 

Ferro-Alloy Resources Limited

Nick Bridgen (CEO) / William Callewaert (CFO)

info@ferro-alloy.com

 

Shore Capital 

(Joint Corporate Broker)

 

Liberum Capital Limited

(Joint Corporate Broker)

Toby Gibbs/Lucy Bowden

 

 

Scott Mathieson/Kane Collings

 

+44 207 408 4090

 

 

+44 20 3100 2000

 

St Brides Partners Limited

(Financial PR & IR Adviser)

Catherine Leftley/Ana Ribeiro

+44 207 236 1177

 

About Ferro-Alloy Resources Limited:

The Company's operations are all located at the Balasausqandiq deposit in Kyzylordinskoye Oblast in the South of Kazakhstan. Currently the Company has two main business activities:

a) the high grade Balasausqandiq vanadium project (the "Project"); and

b) an existing vanadium concentrate processing operation (the "Existing Operation")

Balasausqandiq is a very large deposit, with vanadium as the principal product together with several by-products. Owing to the nature of the ore, the capital and operating costs of development are very much lower than for other vanadium projects.

The most recent mineral resource estimate for ore-body one (of seven) provided an Indicated Mineral Resource of 32.9 million tonnes at a mean grade of 0.62% V2O5 equating to 203,364 contained tonnes of vanadium pentoxide ("V2O5"). In the system of reserve estimation used in Kazakhstan the reserves are estimated to be over 70m tonnes in ore-bodies 1 to 5 but this does not include the full depth of ore-bodies 2 to 5 or the remaining ore-bodies which remain substantially unexplored. 

The Project will be developed in two stages, Stage 1 and Stage 2, treating 1m tonnes per year and an additional 3m tonnes per year. Production will be some 5,600 tonnes of V2O5 from Stage 1, rising to 22,400 tonnes V2O5 after Stage 2 is commissioned.

There is an existing concentrate processing operation at the site of the Balasausqandiq deposit. The production facilities were originally created from a 15,000 tonnes per year pilot plant which was then expanded and adapted to recover vanadium, molybdenum and nickel from purchased concentrates. 

The existing operation is located on the same site and uses some of the same infrastructure as the Project, but is a separate operation which will continue in parallel with the development and operation of the Project.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUWUNROSUKAAR
Date   Source Headline
6th May 20267:00 amRNSNon-Executive Director Share Sale
1st May 20267:00 amRNSGrant of Share Options
30th Apr 20267:00 amRNS2025 Final Results
1st Apr 20267:00 amRNSTotal Voting Rights & Admission of Shares
10th Mar 20267:00 amRNSIssue of Equity
19th Jan 20267:00 amRNSCarbon Black Substitute MOU
5th Dec 20257:00 amRNSIssue of Equity
14th Nov 20254:55 pmRNSResult of 2025 AGM
5th Nov 20257:00 amRNSIssue of Equity
4th Nov 20257:17 amRNSProject Finance Expression of Interest
13th Oct 20257:00 amRNSPositive Feasibility Study Results
9th Oct 20257:00 amRNSNotice of AGM
30th Sep 20257:00 amRNSInterim Results and feasibility study update
7th Jul 20257:00 amRNSIssue of Equity
27th Jun 20257:00 amRNSCBS Product Update and Feasibility Study Update
23rd Jun 20257:00 amRNSAppointment of Lead Financial Adviser
2nd Jun 20257:00 amRNSFramework Agreement for Phase 1 of Balasausqandiq
2nd May 20257:00 amRNSGrant of Share Options
30th Apr 20257:00 amRNS2024 Final Results
6th Mar 20257:00 amRNSIssue of Equity to Supplier
19th Dec 202412:10 pmRNSIssue of Equity to Directors & Share Subscription
17th Dec 20247:00 amRNSNon-Binding Offtake Term Sheet for Balasausqandiq
2nd Dec 20247:00 amRNSStrategic Focus on Carbon Black Substitute
29th Nov 20247:00 amRNSKazakhstan Exempt Offer Bond Programme Update
21st Nov 20247:00 amRNSCommercial Potential of Carbon Black Substitute
24th Oct 20247:00 amRNSQ3 2024 Production Results
23rd Oct 20244:52 pmRNSResult of 2024 AGM
26th Sep 20247:00 amRNSInterim Results
19th Sep 20247:00 amRNSNotice of AGM
18th Jul 20247:00 amRNSQ2 2024 Production Results
29th Apr 20247:00 amRNSFinal Results
26th Apr 20247:00 amRNSQ1 2024 Production Results
15th Feb 20241:00 pmRNSSale of 3rd Tranche of Exempt Offer Bond Programme
1st Feb 20247:00 amRNSFeasibility Study Update & Bond Programme
12th Jan 20247:00 amRNSQ4 2023 Production Results
22nd Dec 20237:00 amRNSTrading Update
30th Nov 20237:00 amRNSTotal Voting Rights
22nd Nov 20237:00 amRNSHolding(s) in Company
21st Nov 202312:17 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSIssue of Equity
1st Nov 20235:08 pmRNSResult of AGM
17th Oct 20237:00 amRNSExempt Offer Bond Programme - Second Tranche Sale
10th Oct 202312:53 pmRNSExisting Operation Q3 Production Results
6th Oct 20237:00 amRNSNotice of AGM
19th Sep 20237:00 amRNSExempt Offer Bond Programme - Second Tranche
12th Sep 20237:00 amRNSInvestor Presentation
12th Sep 20237:00 amRNSGrant of Share Options
11th Sep 20237:00 amRNSHalf-year Report
21st Aug 20237:00 amRNSTrading Update
27th Jul 20239:00 amRNSLaunch of Bond Programme /Listing of First Tranche

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.